UNSPSC 85711538: Supplement right sternoclavicular joint with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right sternoclavicular joint with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RUE4KZ

UNSPSC 85711538 Supplement right sternoclavicular joint with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity. The code names a specific orthopedic surgical procedure, but the recent state and local contract opportunities tagged under it cover occupational medical surveillance, independent disability medical evaluations, surgical benefit carve-out administration, pharmacy benefit management, emergency and specialty medical services for detained youth, and temporary health professional staffing — none of which involve sternoclavicular joint implants or the surgical procedure itself. The mismatch between the code's nominal scope and the work actually being solicited suggests either miscoding by issuing bodies or a data-tagging error in the source records. State and local procurement systems do not commonly solicit for specific orthopedic implants at the Commodity-code tier; such items typically flow through group purchasing organizations, hospital supply contracts, or vendor-direct arrangements outside formal RFP cycles.

The geographic spread of the tagged opportunities spans Arizona (City of Phoenix), California (City of Long Beach and County of Santa Clara), Florida (Collier County), Texas (Harris County), and Washington (Washington State Department of Transportation), but these solicitations represent medical services and staffing contracts rather than implant procurement. Without evidence of actual state and local RFPs, RFQs, or ITBs soliciting sternoclavicular joint supplements or related orthopedic implants under this code, the code does not present a meaningful business development signal for implant vendors. Firms pursuing orthopedic device sales should monitor health system capital equipment requests, surgical supply contracts, and hospital group purchasing agreements instead.